The telehealth company's press release says the price stays flat as doses rise, billed $375 per quarter. Compounded versions are not FDA approved, the release notes.
Recap by typeshit. Full story at markets.businessinsider.com.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Cleveland Clinic notes there's little research and no official guidance on low-dose semaglutide, while trials show far smaller weight loss than standard dosing.
Johns Hopkins researchers report in Annals of Internal Medicine that the pill brought in new patients instead of pulling users away from injectable semaglutide.
Loading…